Alphamab Oncology
Alphamab Oncology
World Rank (Jan-05-2024)
10,036
Market Cap (Jan-05-2024)
0.763 Billion USD
World Rank (Jul-30-2023)
7,658
Market Cap (Jul-30-2023)
1.247 Billion USD
World Rank (Jan-07-2022)
7,472
Market Cap (Jan-07-2022)
1.475 Billion USD
World Rank (Jan-01-2021)
5,519
Market Cap (Jan-01-2021)
1.963 Billion USD
Headquarters Country
World Region
World Subregion
Annual Revenue in USD
21 Million USD
Annual Net Income in USD
60 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
394 Million USD
Total Liabilities in USD
121 Million USD
Total Equity in USD
272 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Ads